Hong Kong venture capital firm, Deep Knowledge Ventures has appointed an artificial intelligence tool to help predict which companies to invest in.

So it has begun, the age when robots slowly climb to the seats of power. Or so it would seem, since biotechnology and regenerative medicine research company Aging Analytics has announced in a press release that the new algorithm they have licensed to a Hong Kong venture capital firm has been appointed to that firm's board of directors.

Aging Analytics licensed their new algorithm or tool called VITAL, which stands for Validating Investment Tool for Advancing Life Sciences, to Deep Knowledge Ventures, a venture fund management company that focuses on mid- to long-term biotechnology investments at their early stage. Deep Knowledge Ventures has appointed VITAL to its board, where it will help the firm by predicting which companies they should invest in.

UP YOUR QUOTA FOR JUST $15 A MONTH
PSFK’s Premium Subscription provides access to a database of over 100,000 articles featuring new ideas, interviews, analysis and opinion on the latest innovation in brand, customer and retail experience.
Already a subscriber? Log in
(powered by Wallkit)